Invaio Sciences, a multi-platform technology company that unlocks the potential of our planet’s interdependent natural systems to solve pressing agriculture, nutrition & environmental challenges, has raised $88.9 million in a Series C financing round led by Stage 1 Ventures, Bluwave Capital, Alexandria Venture Investments, and others. With this financing, Invaio has raised more than $142m since its founding in 2018.
Invaio Sciences is dedicated to developing solutions that are mindful of beneficial insects, bad for pests, and safer for us all.
“Our ambition is to build the most impactful and valuable crop health company on the planet.”
Ignacio Martinez, Co-Founder and CEO of Invaio
Founded by Flagship Pioneering in 2018, Invaio leverages discoveries from diverse fields including human therapeutics, agriculture, environmental science, and advanced manufacturing. The company’s deep understanding of the physiology of insects, plants and trees, together with its novel integrated solutions approach, promises to refine agricultural practices and reduce the need for pesticides globally.
“Since day one at Invaio Sciences, we’ve taken a systems approach to developing a new model for agricultural production in the future. We’re now at the forefront of this discovery. We can cure diseases while reducing the use of pesticides by 90%, and capture more carbon by using precision technologies and investing in the health of the system as a whole.”
Invaio Chief Scientific Officer, Gerardo Ramos.
The company intends to use the capital to roll out solutions for problems including HLB in the citrus industry, Xylella in Olive production, and to institute more refined practices in managing vineyards and orchards. Invaio is also advancing a new carbon offering for perennial producers and is working with the USDA to bolster the vitality of beehives through ensuring pollinator health and the longevity of flowering real food trees in the future.
For more information, please visit www.invaio.com
AgReads® 